Phase II Trial Of Neoadjuvant Axitinib In Patients With Locally Advanced Non-Metastatic Clear Cell Renal Cell Carcinoma

BACKGROUND: Previous studies have shown modest impact of tyrosine kinase inhibitors on primary renal tumors. These studies were mostly retrospective and heterogeneous in their eligibility criteria with regards to histology, disease stage, duration of therapy, and time off therapy prior to surgery. O...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Urol
Autors principals: Karam, Jose A., Devine, Catherine E., Urbauer, Diana L., Lozano, Marisa, Maity, Tapati, Ahrar, Kamran, Tamboli, Pheroze, Tannir, Nizar M., Wood, Christopher G.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4396847/
https://ncbi.nlm.nih.gov/pubmed/24560330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.01.035
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars